Editorial
Cost-effectiveness of immune checkpoint inhibitors in nsclc according to pd-l1 expression
Fecha
2016Registro en:
Lung Cancer Management. London, v. 5, n. 3, p. 119-122, 2016.
1758-1966
10.2217/lmt-2016-0016
WOS:000390431700001
Autor
Aguiar, Pedro, Jr. [UNIFESP]
Perry, Luke A.
Lopes, Gilberto L., Jr.